DOCSLIB.ORG

Gastrointestinal Mediation of Glucose Homeostasis and Postprandial Cardiovascular Risk

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Gastrointestinal Mediation of Glucose Homeostasis and Postprandial Cardiovascular Risk Gastrointestinal mediation of glucose homeostasis and postprandial cardiovascular risk A thesis submitted by Dr Sony Sebastian Thazhath MBBS, MD For the degree of Doctor of Philosophy Discipline of Medicine University of Adelaide February 2016 Table of Contents Table of Contents ..................................................................................................................... II THESIS SUMMARY .................................................................................................................. XII DECLARATION .....................................................................................................................XVIII ACKNOWLEDGEMENTS ........................................................................................................ XX PUBLICATIONS ARISING FROM THE THESIS ............................................................ XXIII STATEMENT OF AUTHORSHIP .......................................................................................... 25 CHAPTER 1. GLUCOSE ABSORPTION IN SMALL INTESTINAL DISEASES .............. 50 1.1 Abstract ........................................................................................................................................ 50 1.2 Introduction ............................................................................................................................... 50 1.3 Physiology of glucose absorption ....................................................................................... 51 1.3.1 Gastrointestinal motility ............................................................................................................... 51 1.3.2 Digestion of carbohydrates .......................................................................................................... 53 1.3.3 Effects of sweet ‘tasting’ by the intestine ............................................................................... 54 1.3.4 Glucose transport across the small intestinal mucosa ..................................................... 56 1.4 Quantification of glucose absorption ................................................................................ 59 1.5 Diseases affecting glucose availability in the small intestine .................................. 61 1.5.1 Disorders of gastric motility ........................................................................................................ 61 1.5.2 Bariatric surgery .............................................................................................................................. 62 1.5.3 Dumping Syndrome ........................................................................................................................ 63 1.6 Disorders of carbohydrate digestion ................................................................................ 64 1.7 Disorders of glucose transporters in the intestinal mucosa ..................................... 65 1.8 Glucose absorption in critical illness ................................................................................ 66 1.9 Glucose absorption in short gut syndrome ..................................................................... 68 1.10 Glucose absorption in type 2 diabetes ........................................................................... 70 1.10.1 Disordered gastric motility ....................................................................................................... 70 1.10.2 Disordered carbohydrate digestion ....................................................................................... 71 1.10.3 Disorders of intestinal ‘sweet tasting’ .................................................................................. 71 1.10.4 Disorders of glucose transporters .......................................................................................... 72 1.11 Expert Commentary .............................................................................................................. 73 1.12 Five year view .......................................................................................................................... 73 1.13 Key issues ................................................................................................................................. 74 Figure 1............................................................................................................................................................ 75 Figure 2............................................................................................................................................................ 76 CHAPTER 2. DIABETIC GASTROPARESIS – RECENT INSIGHTS INTO PATHOPHYSIOLOGY, AND IMPLICATIONS FOR MANAGEMENT. ........................... 78 2.1 Abstract ........................................................................................................................................ 78 2.2 Introduction ............................................................................................................................... 78 2.3 Epidemiology ............................................................................................................................. 79 2.4 Physiology of normal gastric motility ............................................................................... 80 2.5 Motor abnormalities in diabetic gastroparesis ............................................................. 82 2.6 Etiology and natural history of symptoms in diabetic gastroparesis .................... 83 2.7 Pathophysiology of diabetic gastroparesis ..................................................................... 83 2.7.1 Role of nitric oxide as an inhibitory neurotransmitter in diabetic gastroparesis . 84 2.7.2 Role of ICC loss or dysfunction in diabetic gastroparesis................................................ 85 2.8 Diagnosis ..................................................................................................................................... 88 2.8.1 Scintigraphy ....................................................................................................................................... 89 Figure 1............................................................................................................................................................ 90 13 2.8.2 CO2 Breath test .............................................................................................................................. 91 2.8.3 Wireless Motility Capsule (WMC or “Smart Pill”) ............................................................... 91 2.8.4 Ultrasonography ............................................................................................................................... 92 2.8.5 Magnetic Resonance Imaging (MRI) ........................................................................................ 93 2.8.6 Electrogastrography ....................................................................................................................... 93 2.9 Assessment of severity of gastroparesis .......................................................................... 94 2.10 Management ............................................................................................................................ 94 2.10.1 Glycemic control and gastroparesis....................................................................................... 95 2.10.2 Dietary modification in diabetic gastroparesis ................................................................. 98 2.10.3 Prokinetics ....................................................................................................................................... 99 2.10.4 Antiemetics ................................................................................................................................... 102 2.10.5 Pain management ....................................................................................................................... 102 2.10.6 Intrapyloric botulinum injection ......................................................................................... 103 2.10.7 Gastric electric stimulation (GES)........................................................................................ 103 2.10.8 Surgical treatment ...................................................................................................................... 105 2.10.9 Stem Cells ....................................................................................................................................... 105 2.10.10 Psychological disorders and gastroparesis ................................................................... 106 2.10.11 Alternative therapies.............................................................................................................. 106 2.11 Prognosis of diabetic gastroparesis .............................................................................. 107 Figure 2......................................................................................................................................................... 108 2.12 Expert commentary............................................................................................................. 109 2.13 Five-year view ....................................................................................................................... 109 CHAPTER 3. METHODOLOGY ........................................................................................... 111 3.1 Introduction
Load more

Recommended publications
  • Childhood Functional Gastrointestinal Disorders: Child/Adolescent
    Gastroenterology 2016;150:1456–1468 Childhood Functional Gastrointestinal Disorders: Child/ Adolescent Jeffrey S. Hyams,1,* Carlo Di Lorenzo,2,* Miguel Saps,2 Robert J. Shulman,3 Annamaria Staiano,4 and Miranda van Tilburg5 1Division of Digestive Diseases, Hepatology, and Nutrition, Connecticut Children’sMedicalCenter,Hartford, Connecticut; 2Division of Digestive Diseases, Hepatology, and Nutrition, Nationwide Children’s Hospital, Columbus, Ohio; 3Baylor College of Medicine, Children’s Nutrition Research Center, Texas Children’s Hospital, Houston, Texas; 4Department of Translational Science, Section of Pediatrics, University of Naples, Federico II, Naples, Italy; and 5Department of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Characterization of childhood and adolescent functional Rome III criteria emphasized that there should be “no evi- gastrointestinal disorders (FGIDs) has evolved during the 2- dence” for organic disease, which may have prompted a decade long Rome process now culminating in Rome IV. The focus on testing.1 In Rome IV, the phrase “no evidence of an era of diagnosing an FGID only when organic disease has inflammatory, anatomic, metabolic, or neoplastic process been excluded is waning, as we now have evidence to sup- that explain the subject’s symptoms” has been removed port symptom-based diagnosis. In child/adolescent Rome from diagnostic criteria. Instead, we include “after appro- IV, we extend this concept by removing the dictum that priate medical evaluation, the symptoms cannot be attrib- “ ” fi there was no evidence for organic disease in all de ni- uted to another medical condition.” This change permits “ tions and replacing it with after appropriate medical selective or no testing to support a positive diagnosis of an evaluation the symptoms cannot be attributed to another FGID.
    [Show full text]
  • Electrogastrography: Methodology, Validation and Applications
    J Neurogastroenterol Motil, Vol. 19 No. 1 January, 2013 pISSN: 2093-0879 eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.1.5 Review JNM Journal of Neurogastroenterology and Motility Electrogastrography: Methodology, Validation and Applications Jieyun Yin* and Jiande D Z Chen Division of Gastroenterology, University of Texas Medical Branch, Galveston, Texas, USA; and Ningbo Pace Translational Medical Research Center, Beilun, Ningbo, China Electrogastrography (EGG) is a non-invasive method for the measurement of gastric myoelectrical activity. It was first dis- covered in 1921 and popularized in 1990s. EGG is attractive because it is non-invasive. However, due to its non-invasive na- ture, there have also been controversies regarding validity and applications of EGG. The aim of this review is to discuss the methodologies, validation and applications of EGG. Pros and cons of EGG will also be discussed in detail. First, the gastric slow wave and its correlation with gastric motility are presented. The association between gastric dysrhythmia and impaired gastric motility is reviewed. Secondly the method for recording the electrogastrogram is presented in detail and pitfalls in the recording and analysis of EGG are discussed. Thirdly, findings reported in the literature demonstrating the accuracy of EGG in recording gastric slow waves and gastric dysrhythmia are reviewed and discussed. The correlation of the electrogastrogram with gastric contraction is carefully discussed. Finally, applications of EGG in a few major areas are reviewed. (J Neurogastroenterol Motil 2013;19:5-17) Key Words Electrogastrography; Gastric slow waves; Gastrointestinal motility The EGG was first introduced in 1922 by Alvarez,1 redis- covered by Davis et al2 in 1957 and popularized in 1990s.3 Due to Introduction its non-invasive nature, EGG has received substantial attention Electrogastrography is a non-invasive technique for recording among researchers and clinicians and also the controversies and gastric myoelectrical activity using cutaneous electrodes placed concerns arosed.
    [Show full text]
  • 24-Hour Ambulatory Electrogastrography in Healthy Volunteers
    24-Hour Ambulatory Electrogastrography in Healthy Volunteers G. LINDBERG, M. IWARZON & B. HAMMARLLJND Karolinska Institutet, Section of Gastroenterology and Hepatology, Dept. of Medicine, Huddinge University Hospital, Huddinge, Sweden Lindberg G, Iwarzon M,Hammarlund B. 24-Hour ambulatory electrogastrography in healthy volunteers. Sand J Gastroenterol 1996;31:658-664. Background: Development of electrogastrography, the recording of gastric electric rhythm from cutaneous electrodes, for clinical purposes has been hampered by methodologic problems and the lack of an ambulatory technique. We have evaluated a newly developed system for ambulatory electro- gastrography. Methods: 24-Hour recordings were obtained from 30 healthy volunteers. We used digital filtering, a Hamming window, and spectral analysis to determine the dominant frequency of successive 256-sec segments of data. Results: Low-frequency noise disturbed the primary signal. After secondary filtering a stable normogastric (24cpm) rhythm was present during a median of 49% (range, 3679%)of the recording time. The mean frequency of gastric electric activity varied from 2.92 2 0.15 cprn (mean 2 SD) at mid-day to 2.72 2 0.13 cprn in the late night. Conclusions: Ambulatory recording of electrogastrography needs technical improvement. The electrogastrogram shows a circadian variation in frequency. Key words: Electrodes; electrodiagnosis; gastrointestinal motility, computer-assisted signal processing; human; reference values; stomach Greger Lindberg, M.D., Section of Gastroenterology and Hepatology, Dept. of Medicine, K63, Huddinge University Hospital, S-141 86 Huddinge, Sweden (fax: + 46 8 6082241) The recording of gastric electric activity from cutaneous arrive at a so-called running spectral analysis (10, 11). Thus, electrodes, so-called electrogastrography (EGG) was first EGG has shown disturbances of the gastric electric rhythm in described by Alvarez in 1922 (1).
    [Show full text]
  • Clinical Utility of Electrogastrography and the Water Load Test in Patients with Upper Gastrointestinal Symptoms
    J. Smooth Muscle Res. (2006) 42 (5): 149–157 149 Original Clinical utility of electrogastrography and the water load test in patients with upper gastrointestinal symptoms Chien-Lin CHEN1, Chi-Tan HU1, Hsien-Hong LIN1 and Chih-Hsun YI1 1Department of Medicine, Buddhist Tzu Chi General Hospital and University School of Medicine, 707, Sec. 3, Chung-Yang Rd., Hualien 970, Taiwan Received July 31, 2006; Accepted September 14, 2006 Abstract We assessed gastric myoelectric functioning in patients with various gastrointestinal symptoms and to determine the utility of electrogastrography in differentiating specific disease entities. Electrogastrography with a water load was performed in 101 patients with reflux disease, 55 patients with active gastric ulcer, 59 patients with functional dyspepsia, and 30 controls. Upper gastrointestinal symptoms were assessed in each patient. Electrogastrography was abnormal in 41 (40.6%) patients with reflux disease, 31 (56.4%) patients with active gastric ulcer, and 26 (44.1%) patients with functional dyspepsia (P=NS). Water load tolerance was greater in controls than any patient group (all P<0.05). Symptoms predicted abnormal electrogastrography in reflux patents with satiety (OR=2.9; P<0.05) and in dyspeptic patients with nausea (OR=3.1; P<0.05). Although electrogastrography is helpful in differentiating subgroups of patients with nausea or satiety, it cannot directly differentiate disease states such as reflux disease, gastric ulcer, and functional dyspepsia. Key words: electrogastrography, gastric myoelectrical activity, gastrointestinal symptom Introduction Functional dyspepsia (FD) is common and is often defined as episodic or persistent upper abdominal symptoms related to eating (Barbara et al., 1989). Dyspeptic symptoms include vague epigastric or periumbilical discomfort, early satiety, postprandial fullness, bloating, regurgitation, nausea, and vomiting (Drossman, 1999).
    [Show full text]
  • Gastroparesis and Dumping Syndrome: Current Concepts and Management
    Journal of Clinical Medicine Review Gastroparesis and Dumping Syndrome: Current Concepts and Management Stephan R. Vavricka 1,2,* and Thomas Greuter 2 1 Center of Gastroenterology and Hepatology, CH-8048 Zurich, Switzerland 2 Department of Gastroenterology and Hepatology, University Hospital Zurich, CH-8091 Zurich, Switzerland * Correspondence: [email protected] Received: 21 June 2019; Accepted: 23 July 2019; Published: 29 July 2019 Abstract: Gastroparesis and dumping syndrome both evolve from a disturbed gastric emptying mechanism. Although gastroparesis results from delayed gastric emptying and dumping syndrome from accelerated emptying of the stomach, the two entities share several similarities among which are an underestimated prevalence, considerable impairment of quality of life, the need for a multidisciplinary team setting, and a step-up treatment approach. In the following review, we will present an overview of the most important clinical aspects of gastroparesis and dumping syndrome including epidemiology, pathophysiology, presentation, and diagnostics. Finally, we highlight promising therapeutic options that might be available in the future. Keywords: gastroparesis; dumping syndrome; pathophysiology; clinical presentation; treatment 1. Introduction Gastroparesis and dumping syndrome both evolve from a disturbed gastric emptying mechanism. While gastroparesis results from significantly delayed gastric emptying, dumping syndrome is a consequence of increased flux of food into the small bowel [1,2]. The two entities share several important similarities: (i) gastroparesis and dumping syndrome are frequent, but also frequently overlooked; (ii) they affect patient’s quality of life considerably due to possibly debilitating symptoms; (iii) patients should be taken care of within a multidisciplinary team setting; and (iv) treatment should follow a step-up approach from dietary modifications and patient education to pharmacological interventions and, finally, surgical procedures and/or enteral feeding.
    [Show full text]
  • Myoelectric Activity of the Stomach Gastroelectromyography and Electrogastrography
    MYOELECTRIC ACTIVITY OF THE STOMACH GASTROELECTROMYOGRAPHY AND ELECTROGASTROGRAPHY PROEFSCHRIFT TER VERKRIJGING VAN DE GRAAD VAN DOCTOR IN DE GENEESKUNDE AAN DE ERASMUS UNIVERSITEIT ROTTERDAM OP GEZAG VAN DE RECTOR MAGNIFICUS PROF. DR. J. SPERNA WEILAND EN VOLGENS BESLUIT VAN HET COLLEGE VAN DEKANEN DE OPENBARE VERDEDIGING ZAL PLAATS VINDEN OP WOENSDAG 4 JUNI 1980 DES NAMIDDAGS TE 4.15 UUR DOOR ANDREAS JOHANNES PETRUS MARIA SMOUT GEBOREN TE AMSTERDAM DELFT UNIVERSITY PRESS I 1980 PROMOTOREN . : PROF. DR. G. VAN DEN BRINK PROF. DR. D.L WESTBROEK CO-REFERENTEN: PROF. DR. J.TH.F. BOELES PROF. DR. M. FRENKEL aan Anja en Danielle VOORWOORO Aan het tot stand komen van dit proefschrift hebben zeer velen in belangrijke mate bijgedragen. Allen ben ik zeer erkentel ijk. In het bijzonder wil ik alle (vaste en tijdel ijke) medewerkers van de afdel ing Medische Technologie der Erasmus Universiteit danken voor de uitermate plezie­ rige en vruchtbare samenwerking. VI CONTENTS page 1. INTRODUCTION AND OBJECTIVES OF THE STUDIES 2. ANATOMY OF THE STOMACH 3 2.1 Macroscopic anatomy 3 2.2 Microscopic anatomy of intercellular contacts between gastric smooth muscle cells 5 3. INTRACELLULAR ELECTRICAL ACTIVITY OF GASTRIC SMOOTH MUSCLE (LITERATURE SURVEY) 9 3.1 Introduction 9 3.2 Frequencies of action potentials in gastric muscle strips 10 3.3 Configurations of action potentials of gastric muscle 10 3. 3.1 Resting membrane potential 11 3.3.2 Depolarization phase 11 3.3.3 Plateau phase 12 3.3.4 Repolarization phase 15 3.4 Intracellular electrical activity of fundic smooth muscle cells 15 4.
    [Show full text]
  • Chapter 26: Paediatric Gastroenterology
    A National Model of Care for Paediatric Healthcare Services in Ireland Chapter 26: Paediatric Gastroenterology Clinical Strategy and Programmes Division National Clinical Programme for Paediatrics and Neonatology: A National Model of Care for Paediatric Healthcare Services in Ireland TABLE OF CONTENTS 26.0 Introduction 2 26.1 Current Service Provision 4 26.2 Proposed Model of Care 8 26.3 Requirements for Successful Implementation of Model of Care 11 26.4 Governance 13 26.5 Programme Metrics and Evaluation 14 26.6 Key Recommendations 15 26.7 Abbreviations and Acronyms 15 26.8 References 16 1 National Clinical Programme for Paediatrics and Neonatology: A National Model of Care for Paediatric Healthcare Services in Ireland 26.0 INTRODUCTION Paediatric gastroenterology encompasses the management of disorders of the intestine, liver and pancreas, and conditions leading to intestinal failure/severe nutritional compromise. Tertiary paediatric gastroenterology, hepatology and nutrition services for Ireland are provided in one centre, Our Lady’s Children’s Hospital, Crumlin (Crumlin), and will move to the new children’s hospital when it is built. This is in line with international recommendations that specialised services should be delivered in tertiary care centres of excellence. The diagnosis and management of the following tertiary conditions are included among the national paediatric gastroenterology services: • Inflammatory bowel disease (IBD) – medical and surgical care provided centrally, with shared care provided locally by general practitioners
    [Show full text]
  • Minimally Invasive Gastric Electrical Stimulation Using a Newly Developed Wireless Gastrostimulator: a Pilot Animal Study
    J Neurogastroenterol Motil, Vol. 26 No. 3 July, 2020 pISSN: 2093-0879 eISSN: 2093-0887 https://doi.org/10.5056/jnm20063 JNM Journal of Neurogastroenterology and Motility Original Article Minimally Invasive Gastric Electrical Stimulation Using a Newly Developed Wireless Gastrostimulator: A Pilot Animal Study Seung Han Kim,1 Hong Bae Kim,2 Hoon Jai Chun,1* Hyuk Soon Choi,1 Eun Sun Kim,1 Bora Keum,1 Yeon Seok Seo,1 Yoon Tae Jeen,1 Hong Sik Lee,1 Soon Ho Um,1 and Chang Duck Kim1 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Institute of Gastrointestinal Medical Instrument Research, Korea University College of Medicine, Seoul, Korea; and 2Department of Biosystems and Biomaterials Science and Engineering, Seoul National University, Seoul, Korea Background/Aims Gastric electrical stimulation (GES) is a feasible modality for the treatment of gastroparesis; however, the presently available device requires invasive surgical implantation for long-term stimulation and repeated surgical procedure after a period of time. This study is aimed at developing a wireless miniature GES device and testing its endoscopic insertion in animal models. Methods Endoscopic gastric implantation of the GES device was performed on 5 healthy weaner pigs under general anesthesia. We created an endoscopic submucosal pocket and inserted the gastro-electrical stimulator. In vivo gastric slow waves were recorded and measured during electrical stimulation. A multi-channel recorder, called an electrogastrogram, was used to record the gastric myoelectrical activity in the study. Results The gastric slow waves on the electrogastrogram were more consistent with GES on the gastric tissues compared to no stimulation.
    [Show full text]
  • Functional Dyspepsia: a Review of the Symptoms, Evaluation, and Treatment Options
    Functional Dyspepsia: A Review of the Symptoms, Evaluation, and Treatment Options Kimberly N. Harer, MD, ScM, and William L. Hasler, MD Dr Harer is a clinical lecturer and Dr Abstract: The community prevalence of dyspepsia ranges from Hasler is a professor in the Division of 20% to 40%, and dyspepsia accounts for 3% to 5% of primary care Gastroenterology in the University of visits. Dyspepsia symptoms include epigastric pain, epigastric burn- Michigan Health System in Ann Arbor, ing, postprandial fullness, early satiety, epigastric bloating, nausea, Michigan. and belching. Functional dyspepsia is diagnosed when an organic etiology for the symptoms is not identified. Diagnostic symptom- Address correspondence to: based criteria are defined by Rome IV. Functional dyspepsia is Dr William L. Hasler further subclassified into postprandial distress syndrome and University of Michigan Health System epigastric pain syndrome based on the predominance of post- 3912 Taubman Center, SPC 5362 prandial bloating and fullness vs epigastric pain. Evaluation of Ann Arbor, MI 48109 Tel: 734-936-4780 functional dyspepsia is driven by patient age and the presence of Fax: 734-936-7392 red-flag symptoms, such as patients over age 60 years or those with E-mail: [email protected] anemia undergoing evaluation with esophagogastroduodenoscopy. Helicobacter pylori infection should be excluded in all patients. Treatment options include proton pump inhibitors, neuromodu- lators, and prokinetics; however, the evidence supporting these therapies is weak, and the response rate is less than robust. he diagnosis and treatment of functional dyspepsia is often clinically challenging due to factors such as the heterogene- ity of upper gastrointestinal symptoms and the generalized Tpoor response to currently available treatment options.
    [Show full text]
  • Current Status of Multichannel Electrogastrography and Examples of Its Use
    J. Smooth Muscle Res. 2013; 49: 78–88 Published online: March 21, 2013; doi: 10.1540/jsmr.49.78 Review Current status of multichannel electrogastrography and examples of its use Haruaki Murakami, Hideo Matsumoto, Daisuke Ueno, Akimasa Kawai, Takaaki Ensako, Yuko Kaida, Toshiya Abe, Hisako Kubota, Masaharu Higashida, Hiroshi Nakashima, Yasuo Oka, Hideo Okumura, Atsushi Tsuruta, Masafumi Nakamura and Toshihiro Hirai Department of Digestive Surgery, Kawasaki Medical School, Japan Submitted May 30, 2013; accepted in final form November 1, 2013 Abstract Electrogastrography (EGG) is a non-invasive diagnostic motility for recording gastric myoelectrical ac- tivity. Gastric myoelectrical activity was first recorded in 1922. Advances in recording equipment enabled widespread use of cutaneous EGG after 1985. Later, introduction of multichannel EGG (M-EGG) enabled measurement of electrical activity transmission. At present, M-EGG findings are used as objective indicators of gastric motility disorders caused by various diseases. EGG measures two categories of gastric electrical activity: electrical response activity, or spike potentials; and electrical control activity, or slow waves. The appearance of abnormal rhythmic electrical activity is indicative of abnormalities in gastric motility. The normal frequency range of gastric electrical activity (normogastria) is around 3 cycles per min. Multiple EGG parameters assist in the assessment of gastric myoelectrical activity, and significant correlations be- tween EGG and other gastric motility tests have been demonstrated in many studies. In Japan, however, EGG remains in the exploratory stage, and its clinical use is limited. There are large variations in procedures and systems used in previous studies, thus there is a need for standardization of EGG procedures and technical terminology.
    [Show full text]
  • An Experimental Study of the Electrical Activity of the Bypassed Stomach in the Roux-En-Y Gastric Bypass
    ARQGA/1294 AN EXPERIMENTAL STUDY OF THE ELECTRICAL ACTIVITY OF THE BYPASSED STOMACH IN THE ROUX-EN-Y GASTRIC BYPASS Álvaro Antônio Bandeira FERRAZ1, Cristiano Souza LEÃO1, Josemberg Marins CAMPOS1, Antônio Roberto Barros COELHO1, Bruno ZILBERSTEIN2 and Edmundo Machado FERRAZ1 ABSTRACT – Background - Surgical options for morbid obesity are diverse, and the Roux-en-Y gastric bypass, initially described by Fobi has gained popularity. Knowledge about the physiology of the bypassed stomach is limited because this newly produced segment of the stomach is inaccessible to endoscopic or contrast radiological studies. Aim - To evaluate the myoelectric activity of the bypassed stomach and its reply to the feeding. Methods - An experimental protocol was conducted to evaluate postoperative gastric bypassed motility in dogs submitted to the Roux-en-Y gastric bypass procedure. Two groups of five animals were studied on postoperative fasting and after a standard meal, recording electrical response and control activity. Both control and Roux-en-Y gastric bypass operated study group had a pair of electrodes placed on three points of the remaining stomach: fundus, body and antrum. Data registration was performed after complete ileus resolution, and analysed with DATA Q Inst. series 200. Results - The results achieved on the conditions of this study suggest that: 1. the remaining stomach maintain the same pattern of motility; 2. there is a reduced fasting electromyography activity following the Roux-en-Y gastric bypass procedure; 3. significantly reduced fasting electric control activity when compared both groups, and a markedly reduced fasting response electric activity and; 4. the electric response to the feeding kept the same standard of the stomach, however in a statistically reduced way.
    [Show full text]
  • Automatic Classification of Digestive Organs in Wireless Capsule
    Automatic Classification of Digestive Organs in Wireless Capsule Endoscopy Videos Jeongkyu Lee1, JungHwan Oh2, Subodh Kumar Shah1, Xiaohui Yuan2, Shou Jiang Tang3 1Dept. Comp. Sci. & Eng. 2Dept. Comp. Sci. & Eng. 3Division of Digestive Diseases University of Bridgeport University of North Texas UTSW Medical Center Bridgeport, CT 06604 Denton, TX 76203 Dallas, TX 75390 fjelee,[email protected] fjhoh,[email protected] [email protected] ABSTRACT A human digestive system consists of a series of several Wireless Capsule Endoscopy (WCE) allows a physician to di®erent organs including the esophagus, stomach, small in- examine the entire small intestine without any surgical op- testinal (i.e., duodenum, jejunum, and ileum) and colon. eration. With the miniaturization of wireless and camera Standard endoscopy has been playing a very important role technologies the ability comes to view the entire gestational as a diagnostic tool for the digestive tract. For example, track with little e®ort. Although WCE is a technical break- various endoscopies such as gastroscopy, push enteroscopy through that allows us to access the entire intestine without colonoscopy have been used for the visualization of digestive surgery, it is reported that a medical clinician spends one system. However, all methods mentioned above are limited or two hours to assess a WCE video. It limits the number in viewing small intestine. To address the problem, Wire- of examinations possible, and incur considerable amount of less Capsule Endoscopy (WCE) was ¯rst proposed in 2000, costs. To reduce the assessment time, it is critical to develop which integrates wireless transmission with image and video a technique to automatically discriminate digestive organs technology [13, 2, 1, 12, 14, 8].
    [Show full text]